Specialties

Specialties, not a shallow catalog

Each specialty is framed with its actual role inside the platform.

Near-term focus

Phycocyanin

A natural blue fraction from microalgae for color systems and functional ingredients that require batch discipline, purity logic, and stability control.

Natural color systems, nutraceutical actives, premium functional formulations.

First commercial validation line together with valorized biomass.

Near-term focus

Valorized biomass

A disciplined biomass pathway designed to capture value on material output while opening feed, nutrition, or non-food routes according to the actual specification.

Premium feed, biomass pathways, tightly framed functional use cases.

A structural co-output and revenue-supporting pathway from phase one.

Premium margin line

Natural astaxanthin

A high-value specialty aimed at premium segments where process discipline, stability, and traceability carry commercial weight.

Nutraceuticals, premium formulation programs, selective high-value channels.

A premium module activated once the first repeatable base is secured.

Demand-triggered module

Plant-based DHA

A strategic pathway with strong potential, activated only when offtake visibility or recurring customer demand clearly supports module installation.

Specialized nutrition, plant-based formulations, premium application programs.

A future module, not framed as mature broad-scale production without demand proof.

Adjacent capability

Co-products and development services

Co-development, pilot lots, valorization routes, and measured activation of adjacent platform options around the shared industrial backbone.

Pilot lots, formulation support, market testing, valorization workstreams.

A logical platform extension without premature industrial claims.

Positioning logic

A specialty page should inform commercial conversations, not mimic ecommerce.

Every specialty is framed with use cases, role in the platform and maturity nuance so buyers understand what can be discussed now and what belongs to the roadmap.

  • Phycocyanin and biomass sit closer to early commercial validation.
  • Natural astaxanthin is a premium next line, not decorative hype.
  • Plant-based DHA is demand-triggered, not flattened into equal maturity.
  • Co-products and development services extend platform value carefully.